Pharmaceuticals news and pharmaceuticals widget

TEL AVIV (MarketWatch) -- Israeli stocks fell on Tuesday, with all but two of the blue chips declining and the technology and real-estate sectors slumping.

Tokyo, 11 november 2008 - Actavis Group and ASKA Pharmaceutical (Tokyo Stock Exchange: 4514) announce that the companies have concluded a preliminary agreement concerning the establishment of a joint ... [WebWire - Tuesday, November 11, 2008]

CONCORD, ONTARIO (MARKET WIRE) Futuremed Healthcare Income Fund (TSX: FMD.UN) will issue its financial results for the three and nine months ended September 30, 2008 this afternoon, Tuesday november 11, 2008.

Amylin Pharmaceuticals, Inc. announced a corporate restructuring that will reduce its San Diego workforce by approximately 25 percent, or 340 employees, and reduce anticipated 2009 cash expenditures ...

The Board of Directors of Navamedic ASA has decided to focus the company's further development on its Direct Sales and marketing business, through the subsidiary Vitaflo Scandinavia AB. The company ...

Resverlogix Corp. announced that treatment with its lead drug RVX-208, a first in class ApoA-I/Prebeta-HDL elevating drug, in a post-hoc analysis from the Phase 1a clinical trial found that treatment ...

All biological reactions within human cells depend on enzymes. Their power as catalysts enables biological reactions to occur usually in milliseconds. But how slowly would these reactions proceed ...

SAN FRANCISCO (MarketWatch) -- Standard & Poor's said late Tuesday it will replace General Growth Properties Inc. with Cephalon Inc. in the S&P 500. General Growth Properties will be removed from the index after the close of trading on Wednesday, and Cephalon will be added to the index after the close of trading on Friday, S&P said.